NBY News and Press, NovaBay Pharmaceuticals Inc. From 08/11/22

Product revenue increased by 43% year-over-year, fueled by a growing product portfolio in the eyecare and skincare markets Continued year-over-year growth in online Avenova ® Spray unit sales Launched seven new OTC Avenova and DERMAdoctor ® products...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2022 after market close on Thursday, August 11, 2022 and will hold an investment community conference call that day beginning at ...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces the launch of a new marketing campaign targeting the large and growing number of w...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due t...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces the availability of select DERMAdoctor products at two popular U.S. online retaile...

NovaBay Pharma ( NYSE: NBY ) said on Thursday it had record sales of eyecare product Avenova during Amazon’s Prime Day event. The company said sales of Avenova-branded products during the two-day event increased 27% over Prime Days 2021 and 48% over Prime Days 2...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces record sales of Avenova-branded products during Amazon’s Prime Day event (Ju...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that its DERMAdoctor product collections will be featured at Cosmoprof North Ameri...

NovaBay Pharmaceuticals, Inc. (NBY) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Jody Cain - LHA Investor Relations Justin Hall - Chief Executive Officer and General Counsel Andy Jones - Chief Financial Officer Conference Call Participants Destiny Hance - Lade...

NovaBay press release (NYSE:NBY): Q1 GAAP EPS of $0.00 beats by $0.03. Revenue of $2.63M (+45.3% Y/Y) misses by $0.63M. For further details see: NovaBay GAAP EPS of $0.00 beats by $0.03, revenue of $2.63M misses by $0.63M